238 related articles for article (PubMed ID: 26345967)
21. MiR-126 acts as a tumor suppressor in pancreatic cancer cells via the regulation of ADAM9.
Hamada S; Satoh K; Fujibuchi W; Hirota M; Kanno A; Unno J; Masamune A; Kikuta K; Kume K; Shimosegawa T
Mol Cancer Res; 2012 Jan; 10(1):3-10. PubMed ID: 22064652
[TBL] [Abstract][Full Text] [Related]
22. MicroRNAs cooperatively inhibit a network of tumor suppressor genes to promote pancreatic tumor growth and progression.
Frampton AE; Castellano L; Colombo T; Giovannetti E; Krell J; Jacob J; Pellegrino L; Roca-Alonso L; Funel N; Gall TM; De Giorgio A; Pinho FG; Fulci V; Britton DJ; Ahmad R; Habib NA; Coombes RC; Harding V; Knösel T; Stebbing J; Jiao LR
Gastroenterology; 2014 Jan; 146(1):268-77.e18. PubMed ID: 24120476
[TBL] [Abstract][Full Text] [Related]
23. Construction and analysis of dysregulated lncRNA-associated ceRNA network identified novel lncRNA biomarkers for early diagnosis of human pancreatic cancer.
Zhou M; Diao Z; Yue X; Chen Y; Zhao H; Cheng L; Sun J
Oncotarget; 2016 Aug; 7(35):56383-56394. PubMed ID: 27487139
[TBL] [Abstract][Full Text] [Related]
24. Differentially expressed microRNAs in pancreatic cancer stem cells.
Jung DE; Wen J; Oh T; Song SY
Pancreas; 2011 Nov; 40(8):1180-7. PubMed ID: 21785383
[TBL] [Abstract][Full Text] [Related]
25. Cell-free plasma microRNA in pancreatic ductal adenocarcinoma and disease controls.
Carlsen AL; Joergensen MT; Knudsen S; de Muckadell OB; Heegaard NH
Pancreas; 2013 Oct; 42(7):1107-13. PubMed ID: 24048453
[TBL] [Abstract][Full Text] [Related]
26. Next-generation sequencing reveals novel differentially regulated mRNAs, lncRNAs, miRNAs, sdRNAs and a piRNA in pancreatic cancer.
Müller S; Raulefs S; Bruns P; Afonso-Grunz F; Plötner A; Thermann R; Jäger C; Schlitter AM; Kong B; Regel I; Roth WK; Rotter B; Hoffmeier K; Kahl G; Koch I; Theis FJ; Kleeff J; Winter P; Michalski CW
Mol Cancer; 2015 Apr; 14():94. PubMed ID: 25910082
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA in pancreatic cancer.
Yonemori K; Kurahara H; Maemura K; Natsugoe S
J Hum Genet; 2017 Jan; 62(1):33-40. PubMed ID: 27251005
[TBL] [Abstract][Full Text] [Related]
28. Identification of key regulators of pancreatic cancer progression through multidimensional systems-level analysis.
Rajamani D; Bhasin MK
Genome Med; 2016 May; 8(1):38. PubMed ID: 27137215
[TBL] [Abstract][Full Text] [Related]
29. Identification of biomarkers of intrahepatic cholangiocarcinoma via integrated analysis of mRNA and miRNA microarray data.
Chen Y; Liu D; Liu P; Chen Y; Yu H; Zhang Q
Mol Med Rep; 2017 Mar; 15(3):1051-1056. PubMed ID: 28098904
[TBL] [Abstract][Full Text] [Related]
30. Investigating the interference of single nucleotide polymorphisms with miRNA mediated gene regulation in pancreatic ductal adenocarcinoma: An in silico approach.
Mukherjee M; Ghosh S; Goswami S
Gene; 2022 Apr; 819():146259. PubMed ID: 35121024
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis.
Bloomston M; Frankel WL; Petrocca F; Volinia S; Alder H; Hagan JP; Liu CG; Bhatt D; Taccioli C; Croce CM
JAMA; 2007 May; 297(17):1901-8. PubMed ID: 17473300
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA expression profiling and functional annotation analysis of their targets associated with the malignant transformation of oral leukoplakia.
Maimaiti A; Abudoukeremu K; Tie L; Pan Y; Li X
Gene; 2015 Mar; 558(2):271-7. PubMed ID: 25576219
[TBL] [Abstract][Full Text] [Related]
33. Identification of MicroRNAs and target genes involvement in hepatocellular carcinoma with microarray data.
Wang D; Tan J; Xu Y; Tan X; Han M; Tu Y; Zhu Z; Zen J; Dou C; Cai S
Hepatogastroenterology; 2015; 62(138):378-82. PubMed ID: 25916067
[TBL] [Abstract][Full Text] [Related]
34. Screening biomarkers of bladder cancer using combined miRNA and mRNA microarray analysis.
Jin N; Jin X; Gu X; Na W; Zhang M; Zhao R
Mol Med Rep; 2015 Aug; 12(2):3170-6. PubMed ID: 25955758
[TBL] [Abstract][Full Text] [Related]
35. [Research advances in microRNA in pancreatic ductal adenocarcinoma].
Yu CK; Yu SN; Lu ZH; Chen J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Oct; 33(5):575-81. PubMed ID: 22338146
[TBL] [Abstract][Full Text] [Related]
36. Integrated microRNA-mRNA analysis revealing the potential roles of microRNAs in tongue squamous cell cancer.
Zhou XL; Wu JH; Wang XJ; Guo FJ
Mol Med Rep; 2015 Jul; 12(1):885-94. PubMed ID: 25760063
[TBL] [Abstract][Full Text] [Related]
37. Identification of a 5‑microRNA signature and hub miRNA‑mRNA interactions associated with pancreatic cancer.
Ma X; Tao R; Li L; Chen H; Liu Z; Bai J; Shuai X; Wu C; Tao K
Oncol Rep; 2019 Jan; 41(1):292-300. PubMed ID: 30365134
[TBL] [Abstract][Full Text] [Related]
38. The RNA expression signature of the HepG2 cell line as determined by the integrated analysis of miRNA and mRNA expression profiles.
Bai Y; Xue Y; Xie X; Yu T; Zhu Y; Ge Q; Lu Z
Gene; 2014 Sep; 548(1):91-100. PubMed ID: 25014136
[TBL] [Abstract][Full Text] [Related]
39. EFNB2 acts as the target of miR-557 to facilitate cell proliferation, migration and invasion in pancreatic ductal adenocarcinoma by bioinformatics analysis and verification.
Zhang Y; Zhang R; Ding X; Ai K
Am J Transl Res; 2018; 10(11):3514-3528. PubMed ID: 30662604
[TBL] [Abstract][Full Text] [Related]
40. Comprehensive analysis of microRNA/mRNA signature in colon adenocarcinoma.
Wang JY; Wang CL; Wang XM; Liu FJ
Eur Rev Med Pharmacol Sci; 2017 May; 21(9):2114-2129. PubMed ID: 28537673
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
